ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,574,506 | -14.8% | 8,191,502 | +6.3% | 0.00% | 0.0% |
Q2 2023 | $28,830,588 | +7.0% | 7,708,713 | -4.1% | 0.00% | 0.0% |
Q1 2023 | $26,939,816 | -30.3% | 8,041,736 | +0.1% | 0.00% | 0.0% |
Q4 2022 | $38,641,481 | -13.7% | 8,033,572 | +2.1% | 0.00% | -50.0% |
Q3 2022 | $44,789,000 | -14.8% | 7,871,121 | +6.3% | 0.00% | 0.0% |
Q2 2022 | $52,594,000 | +10.0% | 7,407,542 | +11.8% | 0.00% | +100.0% |
Q1 2022 | $47,830,000 | -7.5% | 6,624,693 | +14.6% | 0.00% | 0.0% |
Q4 2021 | $51,684,000 | -64.4% | 5,781,197 | +39.8% | 0.00% | -75.0% |
Q3 2021 | $145,035,000 | +93.4% | 4,136,801 | +18.5% | 0.00% | +100.0% |
Q2 2021 | $74,985,000 | +12.9% | 3,490,963 | +224.6% | 0.00% | 0.0% |
Q1 2021 | $66,412,000 | +20.8% | 1,075,504 | -18.3% | 0.00% | 0.0% |
Q4 2020 | $54,975,000 | – | 1,315,830 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
Atom Investors LP | 30,911 | $219,000 | 0.10% |
FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |